Estrella Immunopharma, Inc. Share Price
ESLAEstrella Immunopharma, Inc. Stock Performance
Open $2.38 | Prev. Close $1.98 | Circuit Range N/A |
Day Range $1.97 - $2.38 | Year Range $0.73 - $3.08 | Volume 7,235 |
Average Traded $2.14 |
Estrella Immunopharma, Inc. Share Price Chart
About Estrella Immunopharma, Inc.
Estrella Immunopharma, Inc., a clinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company's lead product candidate is EB103, which is in clinical trial, for the treatment of diffuse large B-cell lymphoma; EB104, which is in pre-clinical trial, to treat diffuse large B-cell lymphoma and acute lymphocytic leukemia; and EB201, which is in pre-clinical trial, for the treatment of systemic lupus erythematosus. It has a collaborative agreement with Eureka and Imugene Limited for the development of solid tumor treatments using Imugene's product candidate CF33-CD19t in conjunction with EB103. Estrella Immunopharma, Inc. was founded in 2006 and is headquartered in EmeryVille, California.
Estrella Immunopharma, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
12-Nov-25 | $2.38 | $2.10 | +0.00% |
12-Nov-25 | $2.38 | $2.10 | -17.29% |
11-Nov-25 | $2.52 | $2.54 | -3.23% |
10-Nov-25 | $2.90 | $2.63 | -10.54% |
07-Nov-25 | $2.69 | $2.94 | +5.00% |
06-Nov-25 | $2.88 | $2.80 | +10.67% |
05-Nov-25 | $2.36 | $2.53 | +10.24% |
FAQs on Estrella Immunopharma, Inc. Share Price
Can I buy Estrella Immunopharma, Inc. shares in India?
What is the share price of Estrella Immunopharma, Inc.?
What is the 5 year returns of Estrella Immunopharma, Inc.?
What are the high & low stock price of Estrella Immunopharma, Inc. today?
What is the 52-week high and low of Estrella Immunopharma, Inc. stock?